ADM licenses first product in microbiome-targeted tie-up with Gnubiotics 21-Apr-2023 By Jane Byrne ADM has licensed a glycopeptides-based product from Gnubiotics, a Swiss biotech company.
Pet health and wellbeing Gnubiotics inks microbiome focused innovation deal for pet health with ADM 10-May-2022 By Jane Byrne Gnubiotics has secured a strategic partnership agreement with US agribusiness giant, ADM, on microbiome-targeted innovation for pet health and wellbeing.